Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215735
Status:
TERMINATED
Last Update Posted:
2012-03-20
First Post:
2005-09-14
Brief Title:
Effect of Platelet Concentrate in Treatment of Diabetic Ulcers
Sponsor:
Harvest Technologies
Organization:
Harvest Technologies
Study Overview
Official Title:
Clinical Evaluation of the Safety and Effectiveness of Harvest Autologous Platelet Concentrate and Autologous Thrombin for Treatment of Lower Extremity Chronic Diabetic Ulcers
Status:
TERMINATED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
inconclusive results market feasiblity
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Autologous platelet concentrate will enhance the rate of healing of chronic diabetic wounds
Detailed Description:
The treatment of a diabetic wound with APC and thrombinhas the potential to accelerate the re-epithial process when compared with usual care The study is a prospective randomized blinded multicenter clinical evaluation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None